Oncology Corporate Profile
Janssen Diagnostics was established in February 2012 within Janssen Pharmaceuticals R&D, bringing together personnel with diverse healthcare experiences, skills and knowledge across diagnostics, pharmaceuticals and health information technologies from the former Virco, Veridex and Companion Diagnostics Centre of Excellence. We are a global company, based in Beerse, Belgium and Raritan, New Jersey, United States, and employ around 150 professionals from R&D to commercial roles. The strategy of Janssen Diagnostics is to innovate within personalized medicine by developing and commercializing diagnostics and health IT that support treatment decisions in our five major therapeutic areas (e.g. infectious diseases; oncology; neuroscience; cardiovascular and metabolism; and immunology).
|CellSearch®||diagnostic||Circulating Tumor Cell (CTC) Test is a bloodtest that captures and assesses CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer|
This company does not have any pipeline products